Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding its ...
CLEVELAND, May 21, 2025 (GLOBE NEWSWIRE) -- Today, SPR announced the publication of the MONARCH (Multicenter Occipital Neuralgia and Cervicogenic Headache) Study, which evaluates the use of 60-day ...
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
Our SPRINT ® PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain. Backed by the largest body of clinical evidence in peripheral ...